Park Avenue Institutional Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-18,339
Closed -$1.01M 271
2016
Q2
$1.01M Sell
18,339
-104
-0.6% -$5.54K 0.87% 20
2016
Q1
$931K Sell
18,443
-518
-3% -$25.4K 0.8% 26
2015
Q4
$956K Sell
18,961
-674
-3% -$34K 0.82% 25
2015
Q3
$925K Sell
19,635
-423
-2% -$22.5K 0.82% 25
2015
Q2
$1.09M Buy
+20,058
New +$1.12M 0.88% 21

Other funds holding MRK

Park Avenue Institutional Advisers's MRK Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Merck (MRK) in Q3 2016, closing a stake of 18,339 shares — an estimated $1.01M sold.

Park Avenue Institutional Advisers first reported a position in MRK in Q2 2015 and held it in 5 quarters. The position peaked at $1.09M in Q2 2015. 1,814 funds tracked by Wall St. Rank hold MRK as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Merck position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 18,339 Merck shares in Q3 2016, an estimated $1.01M.
  • Park Avenue Institutional Advisers first reported a position in Merck in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Merck position peaked at $1.09M in Q2 2015.
  • 1,814 funds tracked by Wall St. Rank held Merck as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.